Significance of tumour markers in nasopharyngeal carcinoma

Journal of Otolaryngology

Volumn 25, Issue 1, 1996, Pages 32-36

  Kuo, Wen Rei ^a,b   Tsai, Shih Meng ^a   Jong, Shiang Bin ^a   Juan, Kai Hui ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CALCIUM; CARCINOEMBRYONIC ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ALPHA-FETOPROTEINS; ANALYSIS OF VARIANCE; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PEPTIDES; SENSITIVITY AND SPECIFICITY; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0029932246     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bjorklund B, Bjorklund V. Antigenicity of pooled human malignant and normal tissue by cytoimmunological technique: presence of an insoluble heat-labile tumor antigen. Int Arch Allergy 1957; 10:153-183.
2. Bjorklund B, Lundblad G, Bjorklund V. Antigenicity of pooled human malignant and normal tissue by cytoimmunological technique: II nature of tumor antigen. Int Arch Allergy 1958; 12:241-261.
3. Sundram FX, Aw SE, Toh HJ, et al. Significance of tissue polypeptide antigen. (TPA) levels in nasopharyngeal cancer. Ann Acad Med Singapore 1990; 19:156-160.
4. 2-microglobulin as tumor markers in nasopharyngeal cancer. Ann Acad Med Singapore 1986; 15:507-510.
5. Lee YC, Yang PC, Kuo SH, et al. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer. J Formosan Med Assoc 1991; 90:631-636.
6. Chigira M, Shinozaki T. Diagnostic value of serum tumor markers in skeletal metastasis of carcinoma. Arch Orthop Trauma Surg 1990; 109:247-251.
7. Wang WM, Chen CY, Wu CC, et al. Clinical evaluation of serum tissue polypeptide antigen in various cancers. J Formosan Med Assoc 1988; 87:569-573.
8. Bjorklund B. Tissue polypeptide antigen (TPA): biology, biochemistry, improved assay methodology, clinical significance in cancer and other conditions, and future outlook. Antibiot Chemother 1978; 22:16-31.
9. Bast RC, Fenney M, Lazarus H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981; 68:1331-1337.
10. Del Villano BC, Brennan S, Brock P, et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem 1983; 29:549-552.
11. Bjorklund B. On the nature and clinical use of tissue polypeptide antigen (TPA). Tumor Diagn 1980; 1:9-20.
12. Oehr P, Wustrow A, Derigs G, et al. Evaluation and characterization of tumor-associated antigens by the inverse distribution function. Tumor Diagn 1981; 2: 195-202.
13. Nemoto T, Constantine R, Chu TM. Human tissue polypeptide antigen determination in breast cancer. J Natl Cancer Inst 1979; 63:1347-1350.
14. Adolphs HD, Oehr P. Significance of plasma tissue polypeptide antigen determination for the diagnosis and follow-up of urothelial bladder cancer. Urol Res 1984; 12:125-128.
15. Kumar S, Wilson P, Brenchley P, et al. Frequent elevation of tissue polypeptide antigen in the sera of workers exposed to bladder carcinogens. Int J Cancer 1978; 22:542-545.
16. Kew MC, Berger EL. The value of serum concentrations of tissue polypeptide antigen in the diagnosis of hepatocellular carcinoma. Cancer 1986; 58:127-130.
17. Mizushima Y, Hirata H, Izumi S, et al. Clinical significance of the number of positive tumor markers in assisting the diagnosis of lung cancer with multiple tumor marker assay. Oncology 1990; 47:43-48.